A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...
Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...
Add Yahoo as a preferred source to see more of our stories on Google. A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in ...
Scientists have found a breakthrough in the search for a cure for HIV, after research uncovered a development “previously thought impossible”. HIV can ‘hide’ itself in white blood cells, meaning the ...
Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...
Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...
A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...
A public health emergency is about to emerge because of federal ADAP (AIDS Drug Assistance Program) funding cuts. Long since retired, but a public health educator to the end, I’d like to remind ...
UCSF researchers recently gave an overview of their latest work launching a new Institute for HIV Cure Research, funded by a $20 million grant from amfAR, the Foundation for AIDS Research. Cure ...
The shift could cut off tens of thousands of people from treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results